Personality styles in patients with fibromyalgia, major depression and healthy controls

1744-859X-6-9 1744-859X Primary research Personality styles in patients with fibromyalgia, major depression and healthy controls Nordahl M Hans hans.nordahl@svt.ntnu.no Stiles C Tore tore.stiles@svt.ntnu.no

Department of Psychology, NTNU, 7491 Trondheim, Norway

Department of Psychiatry and Behavioural Medicine, NTNU, Box 3008, 7442 Trondheim, Norway

Annals of General Psychiatry 1744-859X 2007 6 1 9 http://www.annals-general-psychiatry.com/content/6/1/9 1734905310.1186/1744-859X-6-9 08 9 2006 09 3 2007 09 3 2007 2007 Nordahl and Stiles; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

The fibromyalgia syndrome (FMS) is suggested to be a manifestation of depression or affective spectrum disorder. We measured the cognitive style of patients with FMS to assess personality styles in 44 patients with fibromyalgia syndrome (FMS) by comparing them with 43 patients with major depressive disorder (MDD) and 41 healthy controls (HC).

Methods

Personality styles were measured by the Sociotropy and Autonomy Scale (SAS) and the Dysfunctional Attitude Scale (DAS). The Structured Clinical interview for DSM Axis I was applied to Axis I disorders, while the Beck Depression Inventory was used to measure depression severity.

Results

Patients with FMS in general have a sociotropic personality style similar to patients with MDD, and different from HC, but FMS patients without a lifetime history of MDD had a cognitive personality style different from patients with MDD and similar to HC.

Conclusion

These findings suggest that a depressotypic personality style is related to depressive disorder, but not to FMS.

Background

Fibromyalgia is characterized by symptoms of chronic widespread pain and stiffness, multiple tender points at specific anatomical sites, chronic fatigue and sleep disturbance 123. Its aetiology remains unknown, although some biological mechanisms have been identified 45. Since fibromyalgia resembles many psychiatric disorders in that it lacks solid evidence of recognizable anatomical alterations, it has been suggested to be a manifestation of hysteria 6, depression 7 or affective spectrum disorder 8. Others have, however, asserted that fibromyalgia is not a psychiatric disorder 9, and that fibromyalgia develop as response to an overactive lifestyle 10 or in the absence of psychological factors 11.

Four studies have examined the occurrence of DSM syndromal disorders in patients with primary fibromyalgia and rheumatoid arthritis 7121314. Two studies found a significantly higher occurrence of a lifetime diagnosis of depressive disorder in fibromyalgia patients than in arthritis patients 713, while the other two did not find group differences in the occurrence of any DSM syndromal disorders 1214. In addition two studies have compared the frequency of lifetime psychiatric disorders in fibromyalgia patients to subjects without a pain syndrome 1215. One of them found that fibromyalgia patients from a tertiary care setting, but not community fibromyalgia residents who had not sought medical care for their symptoms, were significantly more often assigned a depressive disorder, anxiety disorder and somatization disorder compared with healthy controls.

Studies using the Minnesota Multiphasic Personality Inventory 161718 or a similar personality test 19 have shown psychological abnormalities in patients with FMS seen in rheumatological clinics, compared with patients with rheumatoid arthritis and normal controls.

Since fibromyalgia is associated with mood disorders and it has been suggested that FMS is a manifestation of depression or affective spectrum disorder, it is important to assess the cognitive style of patients with FMS because more recent theories 20 have suggested that certain types of cognitions may play a major role in the aetiology, maintenance, and treatment of clinical depression. Beck for example has proposed that cognitions such as dysfunctional attitudes or clusters of depressogenic schemas are trait-like attributes that render individuals vulnerable to depression 20.

Several studies have shown that dysfunctional attitudes and sociotropy, but seldom autonomy, are salient in depressed patients, although it is unclear whether these cognitions are related to depressive disorder, syndrome depression or psychiatric disorder in general 21. However, no studies have so far specifically examined to what extent these cognitions are typical of patients with FMS.

Thus the purpose of the present study was to assess these cognitions in patients with FMS. Since it has been suggested that FMS is intrinsically related to depression, a group of psychiatric outpatients with major depressive disorder (MDD) was included as a comparison group. In addition, a group of healthy controls (HC) was included to assess normal values.

Methods

Subjects

The study consisted of three groups of subjects: 44 patients with FMS, 43 patients with MDD and 41 HC. The patients with FMS were recruited from the local association of fibromyalgia, while the patients with major depression were mainly selected from patients referred to our general psychiatric outpatient clinic. The HC were recruited from the general population living in the same area as the two patient groups.

The fibromyalgia patients underwent a detailed medical history and a thorough clinical examination by a physician at the Department of Physical medicine at the University Hospital. To be included in the study they had to meet the diagnostic criteria of both Smythe 1 and Yunus et al 2. Retrospective investigation of the patients' data revealed that all patients also fulfilled the American College of Rheumatology 1990 (ARC-90) criteria 3. The patients with MDD were included if they met the criteria for a unipolar, nonpsychotic major depressive disorder according to the Structured Clinical interview for a DSM Axis I disorder (SCID-I)2223 and were free of acute and chronic medical disorders. The HC were included if they reported no history of psychiatric disorder, reported no distribution of pain intensity and scored nine or lower on the Beck Depression Inventory 24 indicating normal mood 25.

Psychiatric diagnoses

All patients were diagnosed using the Structured Clinical Interview for Axis I disorders 2223 conducted by an experienced clinical psychologist. The inter-rater reliability was assessed by using a paired-rater design. Videotaped interviews of a diagnostically mixed group of 20 patients were randomly drawn and subsequently observed and rated by another clinical psychologist. Kappa values for Major depressive disorder was 0.92.

Depression severity

The Beck Depression Inventory 24 is a 21-item self-report inventory, which extensively has been shown to be a reliable and valid measure of syndrome depression severity in both clinical and non-clinical populations 25.

Cognitive personality measures

The Dysfunctional Attitudes Scale 26 is a self-report inventory consisting of 40-items designed to measure underlying cognitions that predispose individuals vulnerable for developing depression. Scores range from 40–280, and subjects rate the degree of agreement with each statement on a 7 point Likert scale. Examples of statements include "if I do not do well all of the time, people won't respect me", and "if I fail at work, then I am a failure as a person". Test-retest reliability of two and three months periods are acceptable 27 and validity is evidenced by Hamilton and Abrahamson 28 who reported that depressed patients were observed to have higher DAS scores than both non-depressed patients and healthy controls.

The Sociotropy-Autonomy Scale (SAS) 29 is a 60-item self-report inventory, which measures two stable, independent dimensions of cognitive personality traits called sociotropy and autonomy. Sociotropy refers to dependent traits, characterized by an intense need for love, approval and being esteemed by others. Autonomy is defined as an excessive personal demand for accomplishment and freedom from control by others. Thirty items assess sociotropy and thirty items assess autonomy, and the respondents indicates on a 5-point Likert scale the percentage of time each of the statements describe the respondents thinking and behaviour. Examples of SAS-statements are: "I find it difficult to be separated from people I love" (sociotropy) or "it is important for me to be free and independent" (autonomy). The internal reliabilities of sociotropy and autonomy have been high as indicated by Chronbach alfas of .90 and .83, respectively 29. The test-retest reliabilities over 10 weeks were .80 for sociotropy and .76 for autonomy in student samples 30. The sociotropy scale has demonstrated good convergent validity with other measures of dependency and affiliation 31, but convergent validity seems to be more inconsistent for the autonomy scale 32.

Statistical analysis

Chi-square tests were used to examine possible group differences in the distribution of gender as well as psychiatric diagnoses. Mann Whitney U-tests were conducted to examine potential differences in symptom duration between the two patient groups. Analyses of variance (ANOVAs) were performed to examine group differences in age and depression severity. Overall analyses of covariance (ANCOVAs) were used to analyse the various cognitive personality measures. Age was used as a covariate. ANCOVAs with a significant main effect were followed up with two-group ANCOVAs. P values were considered statistical significant if p < .05.

Results

Demographic and clinical variables

Table 1 presents the demographic and clinical characteristics of the three subjects groups. ANOVA indicated a significant overall group difference in age (F(2,121) = 5.34, p < 0.001). The patients with FMS were significantly older than the patients with MDD (F(1,85) = 16.27, p < 0.001) and the HC (F(1,78) = 9.73, p < 0.01). There were, however, no significant sex differences between groups (χ²(2) = 5.78, p < 0.05) and the two patient groups did not differ in symptom duration (Z = 1.39, p < 0.05).

Table 1

Demographic and clinical characteristics of the three subject groups.

Fibromyalgia

Major depression

Healthy controls

Total (N = 44)

Nondepressed (N = 19)

(N = 43)

(N = 41)

M (SD)

Age (years)

47.3 (12.6)

47.9 (10.9)

38.1 (9.6)

37.8 (11.2)

Symptom duration

13.2 (10.6)

12.9 (9.8)

10.4^a(8.9)

0.0 (0.0)

Beck Depression

Inventory

14.9 (10.1)

10.9 (8.0)

24.1 (6.5)

2.3 (2.6)

N (%)

Female gender

41 (93.2)

17 (89.5)

29 (67.4)

27 (73.0)

Note: a = symptom duration was calculated on the basis of the first onset of a major depressive episode.

As expected, ANOVA indicated a significant overall group difference in depression severity (F(2,121) = 5.26, p < 0.01). Follow up analyses revealed that the patients with MDD were significantly more depressed than both the patients with FMS (F(1,85) = 4.91, p < 0.01) and the HC (F(1,82) = 12.92, p < 0.001), while the patients with FMS were significantly more depressed than the HC (F(1,83) = 14.94, p < 0.001). The patients with FMS and MDD did not differ in the frequency of Generalised anxiety disorder (χ²(1) = 0.2, ns) or Somatoform disorder (χ²(1) = 1.1, ns).

Cognitive personality measures

The means and standard deviations of the various cognitive personality measures for the three groups are presented in table 2.

Table 2

Means and standard deviations of the cognitive personality measures for the three subject groups.

Fibromyalgia

Major depression

Healthy controls

Total (N = 44)

Nondepressed (N = 19)

(N = 43)

(N = 41)

Cognitive measures:

M (SD)

Sociotropy

64.8^a(16.5)

53.3^b(14.7)

73.4^a(16.6)

57.6 (15.7)

Autonomy

65.4 (14.3)

62.6 (15.1)

62.7 (16.3)

66.8 (13.6)

Dysfunctional

Attitudes

107.9^b(19.8)

95.3^b(18.3)

124.2^a(31.2)

99.8 (20.3)

Note. a = p < .05 compared to healthy controls. b = p < .05 compared to major depressed patients.

ANCOVAs with age as covariate indicated that the patients with MDD had significantly higher sociotropic and DAS scores compared to the HC (F(1,82) = 7.21, p < 0.01 and F(1,82) = 5.14, p < 0.05, respectively) and significantly higher DAS scores compared to the patients with FMS (F(1,85) = 3.4, p < 0.05), while the patients with FMS had significantly higher sociotropic scores compared to the HC (F(1,82) = 3.23, p < 0.05). The autonomy scores did not differ between groups. Since the sex distribution was different in the three groups, the three group ANCOVA was repeated by including only the female subjects. The results remained virtually the same, thereby ruling out the potential confounding role of sex.

Since a substantial proportion of the patients with FMS met the criteria for a lifetime history of MDD according to the SCID interview, it was possible that the scores on the cognitive personality measures were confounded by high prevalence of depressive disorder among the patients with FMS. To test this possibility the patients with FMS were subdivided into three subgroups, one consisting of those with a concurrent MDD (N = 13), and one with those without such a history (N = 19) and one with those without a concurrent MDD but with a previous history of MDD (N = 12). ANOVA indicated that the FMS patients without a lifetime history of MDD were significantly less depressed as measured on the Beck Depression Inventory (BDI) both those with a concurrent MDD (F(2,46) = 4.15, p < 0.01) and those with a previous history of MDD (F(2,46) = 1.99, p < 0.05).

Moreover, an ANCOVA with age as a covariate indicated that the FMS patients without a lifetime history of MDD had significantly lower scores on sociotropy than both FMS patients with a concurrent MDD (F(2,44) = 3.06, p < 0.01) and FMS patients with a previous history of MDD (F(2,45) = 3.04, p < 0.01). In addition, FMS patients without a lifetime history of MDD scored significantly lower on the DAS than both FMS patients with a concurrent MDD (F (2,36) = 2.73, p < 0.05) and FMS patients with previous history of MDD (F 2,36) = 2.61, p < 0.05).

ANCOVA with age as a covariate indicated that the patients without a lifetime history of MDD did not differ from the HC on any of the cognitive personality measures, but they had significantly lower sociotropic (F(1,54) = 4.81, p < 0.01) and DAS (F(1,54) = 4.40, p < 0.05) scores compared to the patients with MDD.

Discussion

We found that the patients with MDD had significantly higher sociotropic and DAS scores, but not higher autonomy scores, compared to the HC. This is consistent with earlier studies 21 and partially in accordance with Beck's model of depression 20. The patients with FMS had significantly lower level of dysfunctional attitudes compared to the patients with MDD, and significantly higher sociotropic scores compared to the HC. However, when the effects of both a concurrent and lifetime MDD were controlled for, by only including the patients without a lifetime MDD in the statistical analyses, then it was clearly demonstrated that the patients with FMS have a cognitive personality style which is similar to HC, but significantly different from patients with MDD.

Moreover, FMS patients without a lifetime history of MDD exhibited significantly higher levels of sociotropy and dysfunctional attitudes than both FMS patients with concurrent or previous history of FMS. The results suggest that a cognitive personality style characterised by high sociotropic traits and a high level of dysfunctional attitudes is typical of patients with MDD, but not typical of patients with FMS unless they meet the criteria for a concurrent or lifetime MDD. This is turn contradicts the view that FMS is a variant of depressive disorder 7 or an affective spectrum disorder 8. The present study shows that although the prevalence of depression in patients with FMS is relatively high, cognitive personality styles related to depression are not necessary a part of the FMS. This is also consistent with another recent study showing that concurrent depressive disorder and FMS may be independent, but that the effect of the cognitive appraisals of the FMS symptoms may induce depression in the FMS patients 9.

A contrasting view draws on a recent approach based on a family and gene polymorphism studies. These studies have provided evidence that both mood disorders and enhanced pain sensitivity are found more frequently among the first degree relatives of persons with FMS compared to persons with rheumatoid arthritis or healthy persons 33. Similarly, other studies have demonstrated greater frequencies of gene polymorphisms in the regulatory region of the 5-HTT gene among patients with FMS compared to healthy controls 34. This specific polymorphism is also associated with both MDD and various anxiety disorders. Although this link is not very strong, and observed primarily among women, the link between FMS and MDD may be mediated by genetic or biological factors.

Some limitations of the present study must be considered. First, the patient selection procedures used in the present study may have led to biased sampling of patients, which in turn may limit the generalizability of the results. Since the patients with fibromyalgia were recruited from a member association, it is possible that the sample was biased towards increased psychiatric pathology compared with patients referred to rheumatology clinics and subjects with fibromyalgia who do not seek medical care 15. On the other hand, it has been suggested that patients with fibromyalgia who have psychological problems are more likely to be seen at a rheumatology clinic because of referral bias 35. It is also noteworthy that none of the patients with fibromyalgia were currently in psychiatric treatment, and only a minority of patients with fibromyalgia (18%) had ever sought help. Second, it should be borne in mind that the reliability of one-time assessment of lifetime psychiatric disorder has been reported to be moderate only 36. Third, although our data seems to be internally valid and well controlled based on the phenotypic cognitive style of depressed patients and patients with FMS, these recent studies does not rule out the possibility of a biologically mediated relationship between FMS and MDD, indicating that there could be a relationship on the genotypic level.

Conclusion

There has been a large amount of views and research about the classification of FMS in the last decades. A central issue has concerned to what extent FMS is a form of depression or an affective spectrum disorder. A resolution of this issue is central to both the development of methods and for the understanding of the aetiological processes that underlie FMS. Although there might be a common gene polymorphism in FMS and Major depression, our results indicate that these disorders differ with regard to depressogenic personality style and that major depression in patients with FMS occurs primarily as a sequel to fibromyalgia.

Competing interests

The author(s) declare that they have no competing interests.

Authors' contributions

The authors contributed equally to the manuscript, and both have been involved in drafting of the manuscript and given the final approval of the submitted version.

Acknowledgements

The study has been funded by the Norwegian University of Science and Technology and Østmarka University Hospital. Written consent was obtained from the patients for publication of the study. The authors gratefully acknowledge Sigrid H. Wigers, MD, PH.D for her thorough work in diagnosing the patients with FMS.

Fibrositis: A disorder of pain modulation Smythe HA Clin Rheum Dis 1979 5 823 832 Primary fibromyalgia (fibrositis): A clinical study of 50 patients with matched controls Yunus MB Masi AT Calabro JJ Miller KA Feigenbaum SL Semin Arthritis Rheum 1981 11 151 171 10.1016/0049-0172(81)90096-2 6944796 The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee Wolfe F Smythe HA Yunus MB Bennet RM Bombardier C Goldenberg DL Tugwell P Arthritis Rheum 1990 33 160 172 10.1002/art.1780330203 2306288 Low levels of somatomedin-C in patients with the fibromyalgia syndrome: A possible link between sleep and muscle pain Bennet RM Clark SB Campbell SM Buckhardt CS Arthritis Rheum 1992 35 1113 1116 10.1002/art.1780351002 1418002 Towards a model of pathophysiology of fibromyalgia: Aberrant central pain mechanisms with peripheral modulation Yunus MB J Rheum 1992 9 846 850 "Psychogenic" pain and the pain prone patient Engel GL Am J Med 1959 26 899 918 10.1016/0002-9343(59)90212-8 13649716 Primary fibromyalgia syndrome – a variant of depressive disorder? Alfici S Sigal M Landau M Psychother Psychosom 1989 51 156 161 2636421 Fibromyalgia and psychopathology: Is fibromyalgia a form of affective spectrum disease? Hudson JI Pope HG jr J Rheum 1989 16 15 22 2716005 Evaluation of the relationship between depression and fibromyalgia syndrome: Why aren't all patients depressed? Okifuji A Turk DC Sherman JJ J Rheum 2000 27 212 219 10648041 Premorbid "overactive" lifestyle in chronic fatigue syndrome and fibromyalgia: An etiological factor or proof of good citizenship? Houdenhove BV Neerinck E Onghena P Lysens R Vertommen H J Psychosom Res 2001 51 571 576 10.1016/S0022-3999(01)00247-1 11595245 Fibromyalgia and the facts. Sense or nonsense? Bennet RM Rheum Dis Clin North Am 1993 19 45 59 7689237 Psychiatric status of patients with primary fibromyalgia, patients with rheumatoid arthritis, and subjects without pain: A blind comparison of DSM-III diagnoses Ahles TA Khan SA Yunus MB Spiegel DA Masi AT Am J Psychiatry 1991 148 1721 1726 1957937 Fibromylagia and major affective disorder: A controlled phenomenology and family history study Hudson JI Hudson MS Pliner LF Goldenberg DL Pope HG jr Am J Psychiatry 1985 142 441 446 3856400 Somatisation and depression in fibromyalgia syndrome Kirmayer LJ Robbins JM Kapusta MA Am J Psychiatry 1988 145 950 954 3164984 Psychiatric diagnoses in patients with fibromyalgia are related to health care-seeking behaviour rather than to illness Aaron LA Bradley LA Alarcon GS Alexander RW Triana Alexander M Martin MY Arthritis Rheum 1996 39 436 445 10.1002/art.1780390311 8607892 Psychological factors associated with primary fibromyalgia syndrome Ahles TA Yunus MB Riley SD Bradley JM Masi AT Arthritis Rheum 1984 27 1101 1106 10.1002/art.1780271004 6593072 Fibrositis and psychological disturbance Payne TC Leavitt F Garron DC Katz RS Golden HE Glickman PB Vanderplate C Arthritis Rheum 1982 27 1101 1106 Psychological status in primary fibrositis and fibrositis associated with rheumatoid arthritis Wolfe F Cathey MA Kleinheksel SM Amos SP Hoffman RG Young DY Hawley DJ J Rheum 1984 11 500 506 6592358 Pain perception and personality measure as discriminators in the classification of fibrositis Scudds RA Rollman GB Harth M McCain GA J Rheum 1987 14 563 569 3476752 Cognitive therapy of depression: New perspectives Beck AT Treatment of depression: Old controversies and new approaches New York: Raven press Clayton PJ, Barett JE 1983 Empirical status of the cognitive model of anxiety and depression Clark DA Street RA Frontiers of Cognitive therapy New York: Guilford press Salkowskis PM 1996 75 96 Structured Clinical Interview for DSM-III-R disorders Spitzer RL Williams JBW New York: New York State Psychiatric Institute 1984 The Structured Clinical Interview for DSM-III-R (SCID) I: History, rationale and description Spitzer RL Williams JBW Gibbon M First MB Arch Gen Psychiatry 1992 49 624 629 1637252 Cognitive therapy of depression Beck AT Rush J Shaw B Emery G New York: Guilford press 1979 Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation Beck AT Steer RA Garbin MG Clin Psych Rev 1988 8 77 100 10.1016/0272-7358(88)90050-5 Development and validation of the Dysfunctional Attitudes Scale Weissman AN Beck AT American Educational Research Association Annual Convention Toronto, Canada 1978 Cognitive assessment of depression: Reliability and validity of three measures Dobson KS Breiter HJ J Ab Psychol 1983 92 107 109 10.1037/0021-843X.92.1.107 Cognitive patterns and major depressive disorders Hamilton EW Abramson LY J Abn Psychol 1983 92 173 184 10.1037/0021-843X.92.2.173 Development of the Sociotropy-Autonomy Scale: A measure of personality factors in psychopathology Beck AT Epstein N Harrison R Emery G Philadelphia: University of Pennsylvania 1983 Relations of sociotropic and autonomic personality characteristics to specific symptoms in depressed patients Robins CJ Block P Peselow ED J Abn Psychol 1989 98 86 88 10.1037/0021-843X.98.1.86 The Sociotropy-Autonomy scale: Structure and implications Bieling PJ Beck AT Brown GK Cog Ther Res 2000 24 763 780 10.1023/A:1005599714224 Personality factors in Dysphoria: A psychometric refinement of Beck's Sociotropy-Autonomy Scale Clark DA Beck AT J Psychopath Beh Ass 1991 13 369 388 10.1007/BF00960448 A double blind multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder Arnold LM Lu Y Crofford LJ Wohlreich M Detke MJ Lyengar S Goldstein DJ Arthritis Rheum 2004 9 2974 2984 10.1002/art.20485 Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region Offenbaecher M Bondy B De Jonge S Glatzeder K Kruger M Schoeps P Ackenheil M Arthritis Rheum 2001 11 2482 2488 Relationship of clinical features with psychological status in primary fibromyalgia Yunus MB Ahles TA Aldag JC Masi AT Arthritis Rheum 1991 34 15 21 10.1002/art.1780340104 1984776 Long term reliability of diagnosing lifetime major depression in a community sample Bromet EJ Dunn LO Connell MM Dew MA Schulberg HC Arch Gen Psychiatry 1986 43 435 440 3964022